It was also confirmed that the frequency of the R249S mutation in TP53 revealed the risk of HCC, and TP53 deletion increased the viability of hepatocellular carcinoma cells and the trend of poor prognosis (Lam et al., 2022). Here, TP53 is linked to hepatocellular carcinoma.